Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

FHTX holding history

Foghorn Therapeutics Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FHTX overviewAll 13F holders of FHTXFull Q2 2026 holdings

Shares (Q2 2026)
281,937
Value
$1.38M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of FHTX by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026281,937$1.38M0.6%+207+0.1%AddedHolders
Q1 2026281,730$1.35M0.8%00.0%UnchangedHolders
Q4 2025281,730$1.52M0.9%00.0%UnchangedHolders
Q3 2025281,730$1.38M1.0%−29,200−9.4%ReducedHolders
Q2 2025310,930$1.46M1.5%00.0%UnchangedHolders
Q1 2025310,930$1.13M1.0%00.0%UnchangedHolders
Q4 2024310,930$1.47M1.2%−10,000−3.1%ReducedHolders
Q3 2024320,930$2.99M2.6%00.0%UnchangedHolders
Q2 2024320,930$1.85M1.7%00.0%UnchangedHolders
Q1 2024320,930$2.15M1.8%00.0%UnchangedHolders
Q4 2023320,930$2.07M1.6%+56,087+21.2%AddedHolders
Q3 2023264,843$1.32M1.1%00.0%UnchangedHolders
Q2 2023264,843$1.86M1.4%00.0%UnchangedHolders
Q1 2023264,843$1.64M1.3%00.0%UnchangedHolders
Q4 2022264,843$1.69M1.2%00.0%UnchangedHolders
Q3 2022264,843$2.27M1.6%−20,000−7.0%ReducedHolders
Q2 2022284,843$3.87M2.8%−9,300−3.2%ReducedHolders
Q1 2022294,143$4.48M3.2%−20,000−6.4%ReducedHolders
Q4 2021314,143$7.18M4.6%00.0%UnchangedHolders
Q3 2021314,143$4.38M3.0%00.0%UnchangedHolders
Q2 2021314,143$3.35M2.0%00.0%UnchangedHolders
Q1 2021314,143$4.14M2.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.